Clinical Trials Logo

Non-melanomatous Skin Cancer clinical trials

View clinical trials related to Non-melanomatous Skin Cancer.

Filter by:

NCT ID: NCT00899132 Terminated - Pancreatic Cancer Clinical Trials

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Start date: February 2007
Phase: N/A
Study type: Observational

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is evaluating a tumor marker for testicular cancer, skin cancer, small intestine cancer, and pancreatic cancer.

NCT ID: NCT00747903 Recruiting - Clinical trials for Non-melanomatous Skin Cancer

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer

Start date: February 2008
Phase: Phase 2
Study type: Interventional

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. This may be an effective treatment against skin cancer. PURPOSE: This phase II trial is studying the side effects of photodynamic therapy using aminolevulinic acid and to see how well it works in treating patients with skin cancer.

NCT ID: NCT00663910 Terminated - Clinical trials for Non-melanomatous Skin Cancer

Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer

Start date: March 2008
Phase: Phase 0
Study type: Interventional

RATIONALE: Studying samples of tumor tissue in the laboratory from patients with nonmelanoma skin cancer that has been treated with topical aminolevulinic acid may help doctors predict how patients will respond to photodynamic therapy. PURPOSE: This clinical trial is studying topical aminolevulinic acid in patients with nonmelanoma skin cancer.

NCT ID: NCT00644384 Completed - Clinical trials for Non-melanomatous Skin Cancer

Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer

Start date: February 2003
Phase: N/A
Study type: Interventional

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of acitretin may stop cancer from growing in patients at high risk for basal cell carcinoma or squamous cell carcinoma of the skin. PURPOSE: This randomized trial is studying how well acitretin works in preventing skin cancer in patients at high risk for skin cancer.

NCT ID: NCT00601640 Completed - Clinical trials for Non-melanomatous Skin Cancer

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

Start date: January 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of eflornithine and diclofenac may stop cancer from growing in patients with sun-damaged skin. PURPOSE: This randomized phase II trial is studying the side effects and how well eflornithine works compared with diclofenac, given alone or together, in treating patients with sun-damaged skin.

NCT ID: NCT00433485 Completed - Clinical trials for Non-melanomatous Skin Cancer

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

Start date: n/a
Phase: Phase 1
Study type: Interventional

RATIONALE: Studying samples of blood and tissue from patients with basal cell nevus syndrome and from healthy participants in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to basal cell nevus syndrome. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of sirolimus may keep basal cell skin cancer from forming in patients with basal cell nevus syndrome. PURPOSE: This phase I trial is studying topical sirolimus in patients with basal cell nevus syndrome and in healthy participants.

NCT ID: NCT00423397 Active, not recruiting - Clinical trials for Non-melanomatous Skin Cancer

Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer

Start date: September 2006
Phase: Phase 1/Phase 2
Study type: Interventional

RATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PEG-interferon alfa-2a may interfere with the growth of tumor cells and slow the growth of skin cancer. Giving gefitinib together with PEG-interferon alfa-2a may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of PEG-interferon alfa-2a when given together with gefitinib and to see how well they work in treating patients with unresectable or metastatic skin cancer.

NCT ID: NCT00391300 Active, not recruiting - Melanoma (Skin) Clinical Trials

Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions

Start date: October 2006
Phase: Phase 1
Study type: Interventional

RATIONALE: New diagnostic procedures, such as bioelectric field imaging, may help find and diagnose melanoma and other skin cancers. It may also be a less invasive way to check for skin cancer. PURPOSE: This phase I trial is studying bioelectric field imaging in diagnosing melanoma and other skin cancers in patients with skin lesions.

NCT ID: NCT00295958 Completed - Melanoma (Skin) Clinical Trials

LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery

Start date: December 2005
Phase: Phase 2
Study type: Interventional

RATIONALE: The LMB-2 immunotoxin can find tumor cells and kill them without harming normal cells. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. Giving LMB-2 immunotoxin together with vaccine therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving LMB-2 immunotoxin together with vaccine therapy works in treating patients with metastatic melanoma that cannot be removed by surgery.

NCT ID: NCT00295906 Recruiting - Melanoma (Skin) Clinical Trials

Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control

Start date: June 2004
Phase: N/A
Study type: Interventional

RATIONALE: Computer-based continuing education courses may be effective in improving the skills of primary care doctors to identify skin cancer risk factors, perform skin cancer exams, and counsel patients. They may also improve the skills of primary care doctors to assess and counsel patients on their weight, diet, and physical activity. PURPOSE: This randomized clinical trial is studying how well computer-based continuing education courses work in improving doctors' ability to perform skin cancer or weight control exams and counseling during routine office visits.